The Nutritional Immunology and Molecular Medicine Laboratory (NIMML) has developed a high-resolution model of the gut immune system to help solve emerging and re-emerging infectious diseases and biodefense challenges.
Researchers in China have utilized a two-pronged approach to reduce the Asian tiger mosquito (Aedes albopictus) population by 94 percent in two islands in the city of Guangzhou.
The U.S. Center for Disease Control conducted whole-genome sequencing of a Candida auris isolate from Iran and 74 isolates from other countries and confirmed that the isolate from Iran was genetically distinct from the 4 existing clades. This has resulted in a new clade of Candida auris being identified.
A research team from the University of Minnesota has created a refined method to test for tick-borne diseases by using a mobile laboratory and genetic sequencing targeted at key pathogens.
A small survey by the Society for Healthcare Epidemiology of America (SHEA) Research Network found that while support among healthcare facilities for antimicrobial stewardship rose since 2013, the surveillance for multi-drug resistant organisms either remained at the same level or slightly decreased.
This article discusses the increased biosecurity awareness and practices that have occurred as a result of the African swine fever epidemic.
The World Health Organization (WHO) issued the Health Emergency declaration on Wednesday, July 17, as the Ebola virus has infected over 2,500 people, and killed more than 1,660 during the current outbreak.
Researchers developed a biodegradable synthetic lipid nanoparticle (which more easily penetrates the cell) to deliver CRISPR/Cas9. The nanoparticles encapsulate messenger RNA (mRNA) encoding Cas9. and once the contents of the nanoparticles are released the cell’s protein-making machinery creates Cas9 from the mRNA template.
Two biotechnology startups plan to use CRISPR to develop paper-based diagnostics that would not require the need for Polymerase chain reaction (PCR) or next-generation sequencing.
A study by University of Plymouth researchers suggests that standard disinfectants used by hospitals may no longer be effective in preventing the spread of Clostridioides difficile.